SCHEMBL6352820

SCHEMBL6352820

CCOc1cc(C=C(C(=O)c2cc(OC)c(OC)c(OC)c2OC)C(C)C)ccc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TUBB1 Q9H4B7 8/20 0.41
▸ TUBB4A P04350 6/20 0.41
▸ TUBB P07437 6/20 0.41
▸ TUBA3C P0DPH7 6/20 0.41
▸ TUBA1B P68363 6/20 0.41
▸ TUBA4A P68366 6/20 0.41
▸ TUBB4B P68371 6/20 0.41
▸ TUBB3 Q13509 6/20 0.41
▸ TUBB2A Q13885 6/20 0.41
▸ TUBB8 Q3ZCM7 6/20 0.41
▸ TUBA3E Q6PEY2 6/20 0.41
▸ TUBA1A Q71U36 6/20 0.41
▸ TUBA1C Q9BQE3 6/20 0.41
▸ TUBB6 Q9BUF5 6/20 0.41
▸ TUBB2B Q9BVA1 6/20 0.41
▸ TNFRSF1A P19438 1/20 0.40
▸ CYP1A1 P04798 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ CYP1B1 Q16678 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6603790 0.93 TUBB1 (0.39) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6598545 0.93 TUBB1 (0.47) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6355963 0.91 TUBB1 (0.46) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6600044 0.90 TUBB4A (0.40) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6600203 0.89 MAPT (0.39) TNFRSF1ACYP1A2MAPTKDM4EALDH1A1
SCHEMBL6599803 0.88 TUBB1 (0.47) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6599908 0.88 TUBB1 (0.43) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6346824 0.86 TUBB1 (0.48) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6346286 0.85 TUBB1 (0.42) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6348886 0.85 TNFRSF1A (0.43) TUBB1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050203170-A1 1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof AVENTIS PHARMA S.A. 2005-09-15 — — US disclosed
EP-1453790-A2 1,3-DIARYLPROP-2-EN-1-ONES, COMPOSITIONS CONTAINING SAME AND USE THEREOF Aventis Pharma S.A. (FR) 2004-09-08 — — EP disclosed
US-20040147584-A2 1,3-DIARYLPROP-2-EN-1-ONES, COMPOSITIONS CONTAINING THEM AND USE THEREOF AVENTIS PHARMA S.A. (FR) 2004-07-29 — — US disclosed
US-20030153611-A1 1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof AVENTIS PHARMA S.A. 2003-08-14 — — US disclosed
WO-2003048106-A2 1,3-DIARYLPROP-2-EN-1-ONES, COMPOSITIONS CONTAINING SAME AND USE THEREOF AVENTIS PHARMA S.A. (FR) 2003-06-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147584-A2 1,3-DIARYLPROP-2-EN-1-ONES, COMPOSITIONS CONTAINING THEM AND USE THEREOF MCL1, ENPP1, MYC TUBB1 2020/4885TUBB4A 2448/4885TUBB 2955/4885
US-20050203170-A1 1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof MCL1, ENPP1, MYC TUBB1 2020/4885TUBB4A 2448/4885TUBB 2955/4885
US-20030153611-A1 1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof MCL1, ENPP1, MYC TUBB1 2020/4885TUBB4A 2448/4885TUBB 2955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback